EMR Releases its New Reports on Key Developed Cardiovascular Markets

September 07, 2011
Top Quote EMR's latest publications provide an exceptional tool to understand the current trends, segmentation, competitive landscape and the outlook for key developed cardiovascular drug markets till 2016. End Quote
  • (1888PressRelease) September 07, 2011 - In its new series of reports on cardiovascular drug markets, Expert Market Research, one of the world's leading providers of lifescience market intelligence, analyses the market potential of cardiovascular drugs in key developed markets.
    EMR's Cardiovascular Market Series includes report on the following countries:

    • US Cardiovascular Market Report and Forecast: 2011-2016
    • UK Cardiovascular Market Report and Forecast: 2011-2016
    • Australia Cardiovascular Market Report and Forecast: 2011-2016
    • Japan Cardiovascular Market Report and Forecast: 2011-2016
    • France Cardiovascular Market Report and Forecast: 2011-2016
    • Italy Cardiovascular Market Report and Forecast: 2011-2016
    • Spain Cardiovascular Market Report and Forecast: 2011-2016
    • Germany Cardiovascular Market Report and Forecast: 2011-2016
    • Canada Cardiovascular Market Report and Forecast: 2011-2016

    Each of these reports provide a comprehensive analysis on the current and future market trends of cardiovascular drugs. These reports also facilitate a deep insight into the current and future epidemiology of various cardiovascular disorders and its market structure besides probing into the performance of various segments, companies, molecules and brands. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for cardiovascular drugs.

    Key Questions Answered in this Report:
    • What is the current and future size of the cardiovascular patient population?
    • What are the current and future prevalence rates for various cardiovascular disorders?
    • What has been the historical performance of the cardiovascular market and how will it behave in the coming years?
    • Who are the leading companies in the cardiovascular market and how will they perform in the coming years?
    • What has been the historical performance of various cardiovascular market segments and how will they behave in the coming years?
    • What are the leading drugs in the cardiovascular market and how will they behave in the coming years?

    Why should you buy this Report?
    • To gain an in-depth insight into the prevalence of various cardiovascular disorders.
    • To have it as a powerful tool for identifying your target patient population.
    • To facilitate business decision-making based on historical, current and future market data for cardiovascular drugs.
    • To identify potential segments, drugs, partners and competitors so as to develop strategies for market penetration and drug development
    • To develop business strategies by looking at companies those have been the biggest winners and losers in the cardiovascular market.
    • To gain an understanding into future market events and make more informed business decisions.

    Research Objectives Achieved in this Report:

    Evaluating the Epidemiology of Various Cardiovascular Disorders:
    Key Aspects Analyzed:
    • Current and future prevalence of various Cardiovascular disorders
    • Current and future size of the cardiovascular patient pool
    Comprehensive Situation Analysis of the Cardiovascular Market:
    Segments Covered: Hypertension, Dyslipidemia, Thrombosis, Arrhythmia & Chronic Heart Failure.
    Aspects Analyzed in Each Segment
    • Historical and current market trends
    • Performance of top companies
    • Market forecast

    Methodology & Information Sources:
    To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K's, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.

    Table of Contents
    1. Research Methodology & Definitions
    2. Executive Summary
    3. Cardiovascular Disorders: Prevalence & Patient Population
    3.1 Prevalence of Various Cardiovascular Disorders
    3.2 Cardiovascular Patient Pool
    4. The Cardiovascular Drugs Market Landscape
    4.1 Current Trends & Forecast
    4.1.1 Current Market Trends
    4.1.2 Market Forecast
    4.2 Share of Various Players & Drugs
    4.2.1 Current Trends
    4.2.2 Market Forecast
    4.3 Performance of Various Segments
    4.3.1 Hypertension
    4.3.1.1 Current Market Trends
    4.3.1.2 Sales of Key Players
    4.3.1.3 Sales Forecast
    4.3.2 Dyslipidemia
    4.3.2.1 Current Market Trends
    4.3.2.2 Sales of Key Players
    4.3.2.3 Sales Forecast
    4.3.3 Thrombosis
    4.3.3.1 Current Market Trends
    4.3.3.2 Sales of Key Players
    4.3.3.3 Sales Forecast
    4.3.4 Arrhythmia
    4.3.4.1 Current Market Trends
    4.3.4.2 Sales of Key Players
    4.3.4.3 Sales Forecast
    4.3.5 Chronic Heart Failure
    4.3.5.1 Current Market Trends
    4.3.5.2 Sales of Key Players
    4.3.5.3 Sales Forecast

    To buy the complete report or to get a free sample:
    Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
    Email: sales ( @ ) expertmarketresearch dot com
    To know more please visit: http://www.expertmarketresearch.com

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
Over Satisfied Users & Approved Press Releases
© Copyright 2005-2024, 1888 Press Release. All Rights Reserved